Netflix

Company NFLX

Last mentioned: 13h ago

Share

Across the most recent 14 stories covering Netflix — 29% positive, 29% negative, 43% neutral sentiment, averaging 7.2/10 impact.

This entity profile aggregates every story where the entity meets our minimum relevance threshold before it is linked here — a story naming this entity only in passing, as competitive context for an unrelated subject, does not qualify. That threshold exists because earlier testing surfaced entity pages cluttered with tangential mentions: a story about two unrelated companies merging could otherwise populate a third company's page simply because it was named once for comparison, with no real event of its own. The timeline below reflects genuine milestones and developments specific to this entity, cross-referenced against the same source-verification standard applied to every story on this site. Sentiment measures the directional read of each development for this entity specifically, not the overall tone of the reporting, and impact weights how consequential a development is rather than how widely it was syndicated across outlets.

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

Timeline

  1. Regulatory Review

    Anticipated commencement of federal antitrust investigations into the proposed merger.

  2. Payment Date

    Distributions are credited to eligible shareholder accounts.

  3. Distribution Declaration

    Official announcement of the quarterly payout amounts for OVM and NFLS.

  4. Record Date

    The date on which the company identifies all current stockholders.

  5. Netflix Withdrawal

    Netflix officially declines to raise its offer or match the terms set by Paramount.

  6. Board Endorsement

    The Warner Bros. Discovery board of directors formally backs the Paramount bid.

  7. Paramount Bid Submitted

    Paramount Global submits a formal acquisition bid for Warner Bros. Discovery.

  8. Superior Determination

    WBD board formally labels the Paramount bid as potentially superior.

  9. White House Visit

    Netflix executives reportedly fail to win over regulatory support in Washington.

  10. Revised Proposal

    Paramount submits a higher, revised bid to the WBD board.

  11. Board Ruling

    WBD board labels Paramount offer as 'superior,' triggering a 4-day matching period for Netflix.

  12. Regulatory Milestone

    The regulatory waiting period for Paramount's initial Warner bid expires.

  13. Paramount Bid

    Paramount-Skydance submits a formal $111 billion offer for WBD.

  14. Talks Reopen

    Warner Bros. Discovery reopens sale talks as market interest intensifies.

Stories mentioning Netflix 14

Earnings Bearish

Netflix Hits 52-Week Low After Earnings, but $4.7B Buyback Signals Confidence

Netflix’s slight Q2 revenue miss and soft guidance triggered an after-hours plunge to a 52-week low, extending a 44% drop from its all-time high. Yet a record $4.7 billion buyback and $27 billion remaining authorization suggest management sees deep undervaluation. Analysts urge investors to focus on cash generation and long-term margins rather than quarterly engagement noise.

2 sources

Source: fortune.com · memeburn.com

Markets Neutral

Netflix Declines to Match Paramount Bid for Warner Bros. Discovery

Netflix has officially declined to raise its offer for Warner Bros. Discovery, effectively ending a potential bidding war. The WBD board has formally endorsed Paramount’s competing bid, clearing the path for a massive consolidation in the media and streaming landscape.

2 sources
Markets Neutral

Paramount Raises Bid for Warner Bros Discovery to Counter Netflix Threat

Paramount Global has submitted a significantly higher offer to acquire Warner Bros Discovery, aiming to consolidate the legacy media landscape. The strategic move is designed to create a content powerhouse capable of blocking Netflix's market dominance and securing survival in the competitive streaming era.

2 sources
Markets Neutral

Pharma's 'Netflix' Pivot: Solving the Antibiotic Market Failure

Health experts and economists are advocating for a subscription-based 'Netflix' model for antibiotics to combat the rise of superbugs. This proposed shift aims to decouple pharmaceutical profits from sales volume, incentivizing R&D in a sector currently plagued by market failure.

3 sources

About Netflix coverage

This page surfaces every story mentioning Netflix across our finance coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running finance beat. Cross-entity comparisons live on our compare view.

Entities only appear on this page once the classifier scores them at a minimum 35 percent relevance to the story, filtering out passing mentions. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.

What you seeWhat it tells you
Story countNumber of distinct stories where Netflix was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.